AMIX
Autonomix Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$4.21
−1.64%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$4.39
From 52W high−84.09%
Volume32208.00
Market cap$8.25M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataSep 18, 2026
Open
$4.39
From 52W high
−84.09%
Volume
32208.00
Market cap
$8.25M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.3x
P/E (TTM)
—
RSI (14)
41.7
MomentumView details →
1D Return
−1.64%
YTD Return
−63.23%
SummaryUpdated Jun 1, 2026
Autonomix Medical, Inc. (NASDAQ:AMIX) is a development-stage medical device company founded in 2014 and based in The Woodlands, Texas. The company went public in January 2024 and focuses on developing innovative technologies for sensing and treating disorders related to the peripheral nervous system. As a pre-revenue company, Autonomix is currently in the research and development phase, working to advance its proprietary catheter-based sensing technology platform.
Similar companies
Latest newsMore news →
Autonomix Medical, Inc. appointed Sandra Kalter as an independent member of its Board of Directors, effective September 14, 2026.4d agoAutonomix Medical entered into a warrant inducement agreement with an investor for the immediate exercise of existing warrants to purchase 857,462 shares at $5.75 per share, expecting gross proceeds of approximately $4.9 million, and will issue new Series E-1 and E-2 warrants for 1.07 million shares.26d ago